A FORMER KwaZulu-Natal North Coast resident has had a prominent hand in breakthrough multi-cancer early detection test technology that could potentially “light the way” to reduced mortality rates and treatment costs.Wesley Sukdao is the CEO and co-founder of Proteotype Diagnostics LTD, a UK-based company that produced Enlighten, a laboratory test system that detects cancer as early as the immune system does.The cancer diagnostics norm has generally been to rely on tumour-released signals that only become apparent once the disease has progressed appreciably, which could ultimately…